Banting Science Achievement Award Recipient: Development of Amyloid Inhibitors Promising to Slow T2DM Progression

At the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), the presentation of the Banting Medal for Scientific Achievement was undoubtedly one of the most anticipated highlights. As the highest scientific honor of the ADA, this award commemorates Dr. Frederick Banting—the medical scientist, physician, and Nobel laureate who played a pivotal role in […]

Professor Chen Liming: Say Goodbye to Daily Dosing Biweekly DPP-4 Inhibitor Provides More Stable Glycemic Control, Higher Patient Satisfaction, and Long-Term Benefits

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Stable glycemic control is critical not only for quality of life—including daily energy, appetite, and sleep—but also for preserving islet function and preventing long-term complications. As the 2026 American Diabetes Association (ADA) guidelines further expand the eligible population for continuous glucose monitoring (CGM), precise evaluation […]